Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)
Clinical trial NCT06852768 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06852768
- Sponsor
- Regenerative Ocular Immunobiologics LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-10
- Primary completion
- 2026-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.